Ablation of proliferating cells in CNS decreases lifespan of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

TA1 results in a decreased <i>in vivo</i> inflammatory response upon allogeneic cells challenge. by Duncheng Wang (838084)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

No contribution of TGF-α, protein phosphatase 5 or protein kinase A to decreased levels of secreted Hsp90. by Stefan Tukaj (439533)

Astrocytes express a ligand for NKp44 and increasing concentrations of HIV 3S peptide decreases its expression. by Kelly E. Bowen (4857370)

Signaling via a number of pathways was decreased in <i>PAPST</i>-KD cells during EB formation. by Norihiko Sasaki (144478)

PpL decreases the expression of IgM and κ chain in a human malignant B cell line. by Daniela Lorenzo (358445)

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

(A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells by Masakatsu Yamashita (46657)

Exogenous recombinant heparanase (rHPSE) decreases nuclear syndecan-1 levels in a concentration-dependent manner. by Ligong Chen (259976)

PF treatment decreases the mRNA expressions of TNFα (A) and IL-1β (B) in the brain. by Ruo-Bing Guo (298949)

In primary cultures of differentiated subcutaneous (a) and omental (b) pre-adipocytes, Dex decreases lipogenesis in the absence of insulin. by Laura L. Gathercole (341979)

ARΔTR-transduced CWR-R1 cells demonstrate decreased proliferation in the presence of DHT. by Mark A. Titus (335248)

Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

Decreased trabecular bone mass in <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells. by Mariam El-Ashmawy (678638)

Gephyrin dominant-negative chimera decreased gephyrin and GABA_AR γ2 clustering. by Marianne Renner (142651)

BH₄ bioavailability was decreased in cortical and hippocampal microvessels as compared to microvessels from the cerebellum. by Susan A. Austin (768265)

CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex. by Teemu Natunen (398069)

“…(B) Aβ42-ELISA demonstrates a significant decrease in the soluble Aβ42 levels in the temporal cortex of patients with CC genotype as compared to the TT genotype (*p<0.05, ANOVA LSD, n = 33/34/16, rs7120118 genotypes TT/CT/CC, respectively). …”

Living cells are decreased in the PDL on the pressure side of a Pn−/− molar tooth subjected to experimental tooth movement. by Hideyuki Tanabe (243557)